All HEI'sAthlone Institute of TechnologyCork Institute of TechnologyDublin City UniversityDublin Institute of TechnologyMaynooth UniversityNational University of Ireland, GalwayRoyal College of SurgeonsTeagascTrinity College DublinUniversity College CorkUniversity College DublinUniversity of LimerickWaterford Institute of Technology All SectorsFuture Networks and Communications, IoT Data Analytics, Management, Security, Privacy, Robotics and Artificial Intelligence (incl. Machine Learning)Digital Platforms, Content and Applications, Augmented & Virtual RealityConnected Health Medical DevicesDiagnosticsTherapeutics Food for HealthSmart & Sustainable Food Production and Processing Decarbonising the Energy SystemSustainable LivingAdvanced & Smart ManufacturingManufacturing & Novel MaterialsInnovation in Services and Business ProcessingSectorsResearch Theme Sub SectorsAge Related Macular Degeneration - Licensing Opportunity from Trinity College Dublin - July 2015Age-related-macular-degeneration (AMD) is the leading cause of central vision loss worldwide. Drusen accumulation is the major pathological hallmark common to both dry and wet AMD. While activation of the immune system h... pdf 997.9KBNovel Vaccine Components for Whooping Cough - Licensing Opportunity from Trinity College Dublin - July 2015Novel Toll-like receptor 2 (“TLR2”) agonists endogenously derived from Bordetella pertussis, have been discovered and have considerable potential for the development of a more effective vaccine capable of generating prot... pdf 1.2MBCartilage Repair Therapy - Licensing Opportunity from Trinity College Dublin - July 2015Articular cartilage injury or degeneration is a common disorder of joints, affecting people of all ages. More than 500,000 cartilage repair procedures are performed annually in the United States alone. The intrinsic rang... pdf 1.1MBNovel Biomarker for Multiple Myeloma Diagnosis and Prognosis - Licensing Opportunity from National University of Ireland Galway - March 2015Multiple Myeloma is a highly prevalent disease accounting for 1-2% of all cancers, with a market size for treatments estimated to grow to $7 billion by 2020. This technology will prove to be extremely valuable in fightin... pdf 1.2MBNovel Marker for the Isolation of Pure Mesenchymal Stem Cell populations - Licensing Opportunity from National University of Ireland Galway - March 2015MSCs are being developed to treat a host of human diseases, however they are present in extremely small numbers in the body. This technology allows for the effective and efficient isolation and purification of these rare... pdf 1.2MB First 1234567891011121314151617181920212223242526 Last Print Bookmark Top